First Republic Investment Management, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$20.56 - $63.12 $216,908 - $665,916	-10,550 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $296,877 - $770,255	10,550 New	10,550 $669,000
Q3 2019 Nov 08, 2019	SELL	$26.26 - $34.86 $224,890 - $298,541	-8,564 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$17.43 - $28.82 $123,944 - $204,939	-7,111 Reduced 45.37%	8,564 $227,000
Q1 2019 Apr 30, 2019	BUY	$12.05 - $20.18 $2,916 - $4,883	242 Added 1.57%	15,675 $288,000

Q4 2018 Feb 12, 2019	BUY	$10.74 - $19.7 $10,740 - $19,700	1,000 Added 6.93%	15,433 $192,000
Q3 2018 Nov 13, 2018	BUY	$14.0 - $20.3 $202,062 - $292,989	14,433 New	14,433 $277,000

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account